◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksV › VME

Viromed Medical AG (VME) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-09-19

Viromed Medical AG (VME) operates in the Medical Devices industry and is headquartered in Pinneberg, Germany with about 17 employees. Its market capitalization is roughly €118 million. In the fiscal year ended 2025-12-31, VME reported €5M in revenue and €1M in net income.

Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.

Interactive charts & full statements →

VME Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total Revenue€5M€1M€0M€0M
Gross Profit€2M(€0M)
Operating Income (EBIT)(€1M)(€4M)(€0M)(€0M)
Net Income€1M(€3M)(€0M)(€0M)

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VME Free Cash Flow History

VME Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets€14M€13M€20M€20M
Total Liabilities€3M€4M€0M€0M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VME viewer.

Other Companies in Medical Devices

← VMDAll “V” companiesVMET →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.